Corporate America has transformed the management of people into a numbers game - effectively devaluing the human element in corporate performance. Even new terminology used to describe human resource practices in business, Human Capital Management, is sanitary and connotes a loss of the human touch. Organizations that are surviving these economic times better than others understand the true value of their people and the hidden qualities that can’t be quantified, which nonetheless affect the bottom line.

The life sciences industry has traditionally relied on the foundation of a few key blockbuster drugs and premium prices to drive profits while they actively pursued the next game-changing drug approval. For years, pharmaceutical companies have prospered on generous margins and new breakthroughs during thriving economic periods, but times have changed.

Your objective is clear: bring new drugs to market faster, more efficiently and at lower cost. To do this you must navigate the challenging waters of the clinical trial process. A key success factor during clinical trials is to insure the clinical trial supply chain process works extremely well.